Skip to content

Screening for Social Weaknesses and Coordination Course of Cancer Patients

Screening for Social Weaknesses and Coordination Course of Cancer Patients: A New Approach by an Expert System IT

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02369783
Acronym
DEFCOCANCERO
Enrollment
71
Registered
2015-02-24
Start date
2014-07-31
Completion date
2015-02-28
Last updated
2016-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The main objective of the study is to validate a methodology with Psychometric tool to measure levels of patients social fragility. This tool will be dematerialized on a tablet. The answers will be then processed by a decision support algorithm, which automatically send an alert to detection of social fragility of the patient to the nurse navigators.

Interventions

The aim is to detect social fragility.

Sponsors

Institut de Cancérologie de la Loire
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All new patients enter ICLN for a diagnosis of cancer * Patients who can read French or patients who can not read French, but accepting the translation by a close friend or family * Patient having signed a free and informed consent

Exclusion criteria

* Refusal of participation, major patients protected under guardianship. * Patient can not read French without possibility of translation by a close friend or family

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire validity1 hourOutcomes are content validity by expert judges method, appearance validity through a consensus, construct validity through exploratory factor analysis, discriminant validity in relation to the social fragility through univariate analysis, internal validity through factor analysis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026